RSS Feed
Search Ask-Cato.com
Tags
adverse events biologics biosimilar biotech cancer Cato BioVentures Cato Research CDER clinical investigator clinical research clinical trials CMC conference CROs DIA drug development eCTD efficacy FDA funding GlobalSubmit guidance Health Canada IND in vitro diagnostics labeling manufacturing marketing application medical devices NDA NIH nonclinical research oncology Phase 1 Phase 2 postmarketing protocol regulatory affairs safety statistical analysis toxicology transparency venture capital warning letters webinarCategories
- Clinical Trials (52)
- Conferences and Meetings (34)
- eCTD (26)
- FDA (71)
- Guest Posts (5)
- Health Canada (6)
- Industry News (56)
- Project Management (1)
- Publications (7)
- Regulatory Strategy (36)
- Social Media (6)
- Statistics (9)
- Uncategorized (1)
- Venture Capital (10)
- Webinars (24)
Tag Archives: Barcelona
Cato at the 12th World Congress on Gastrointestinal Cancer
Cato Research will be attending the European Society for Medical Oncology‘s (ESMO) 12th World Congress on Gastrointestinal Cancer in Barcelona, Spain from 30 June to 03 July 2010. ESMO is the leading European professional organization representing medical oncologists. The conference … Continue reading →
Posted in Conferences and Meetings |
Tagged Barcelona, cancer, clinical trials, Colorectal cancer, European Society for Medical Oncology, immune system, oncology |
Comments Off
